Table 2.
HPV vaccine initiation by source of information (n = 617)
| n initiated/total | Weighted % | Bivariate OR (95% CI) | Multivariate OR (95% CI) | |
|---|---|---|---|---|
| Drug company ad | ||||
| No | 81/217 | 37.7 | ref. | -- |
| Yes | 115/390 | 28.0 | 0.65(0.41–1.01) | -- |
| Healthcare provider | ||||
| No | 56/313 | 16.4 | ref. | ref. |
| Yes | 141/301 | 45.7 | 4.28(2.61–6.99)* | 2.87(1.69–4.87)* |
| News/Internet | ||||
| No | 105/303 | 34.4 | ref. | -- |
| Yes | 87/304 | 27.0 | 0.71(0.46–1.10) | -- |
| Daughter’s school | ||||
| No | 178/559 | 30.3 | ref. | -- |
| Yes | 18/50 | 41.4 | 1.60(0.77–3.36) | -- |
Note. HPV = human papillomavirus, OR = odds ratio, CI = confidence interval, ref. = referent group. Does not include respondents who did not know if they had heard about HPV vaccine from this source (drug company advertisement n=10; healthcare provider n=3; news/Internet n=10; and daughter’s school n=8). Multivariate model controlled for variables previously found to be associated with HPV vaccine initiation in this data set (daughter’s age, daughter’s preventive check-ups within the past 12 months, meningococcal vaccine for daughter, flu vaccine for parent, and urbanicity).9
*
p<0.05